Total debt of $23.4M against $579.3M of equity (debt-to-equity of roughly 0.04) and a current ratio between 1.53 and 2.11 suggest minimal refinancing exposure, though goodwill rising from $28.7M to $119.6M and deferred revenue reading $0 in 2026Q3 warrant further investigation.
Cellebrite DI Ltd. (CLBT) balance sheet — 7-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 |
|---|
| Total Current Assets | 658.41M | 575.85M | 567.59M | 422.08M | 295.93M | 273.21M | 324.27M | 261.88M |
| Cash & Short-Term Investments | 483.87M | 437.05M | 447.22M | 302.92M | 183.62M | 181.56M | 237.64M | 200.25M |
| Cash Only | 223.06M | 124.46M | 191.66M | 189.52M | 87.64M | 145.97M | 128.71M | 76.55M |
| Short-Term Investments | 260.81M | 312.59M | 255.56M | 113.41M | 95.98M | 35.59M | 108.93M | 123.71M |
| Accounts Receivable | 139.82M | 104.97M | 82.36M | 77.27M | 78.76M | 67.5M | 66.32M | 44.24M |
| Days Sales Outstanding | 72.74 | 80.55 | 74.93 | 86.75 | 106.22 | 100.06 | 124.2 | 93.95 |
| Inventory | 7.51M | 7.6M | 8.94M | 9.94M | 10.18M | 6.51M | 4.75M | 3.96M |
| Days Inventory Outstanding | 29.71 | 36.92 | 52.13 | 68.16 | 73.19 | 55.84 | 45.81 | 40.35 |
| Other Current Assets | 5.84M | 6.59M | 18.18M | 23.06M | 14.77M | 7.88M | 11.24M | 8.86M |
| Total Non-Current Assets | 410.07M | 363M | 122.97M | 123.86M | 107.36M | 66.57M | 40.12M | 18.36M |
| Property, Plant & Equipment | 43.58M | 38.52M | 27.6M | 30.16M | 32.91M | 16.76M | 16.11M | 14.82M |
| Fixed Asset Turnover | 13.22x | 12.35x | 14.54x | 10.78x | 8.22x | 14.70x | 12.10x | 11.59x |
| Goodwill | 119.56M | 119.56M | 28.71M | 26.83M | 26.83M | 26.83M | 9.46M | 0 |
| Intangible Assets | 117.93M | 81.47M | 11.31M | 10.59M | 11.25M | 11.23M | 6.61M | 0 |
| Long-Term Investments | 416.05M | 97.96M | 36.6M | 28.86M | 22.13M | 0 | 0 | 0 |
| Other Non-Current Assets | 19.59M | 14.62M | 7.68M | 12.89M | 1.73M | 1.96M | 565K | 447K |
| Total Assets | 1.07B | 938.85M | 690.57M | 532.88M | 403.29M | 339.78M | 364.39M | 280.24M |
| Asset Turnover | 0.54x | 0.51x | 0.58x | 0.61x | 0.67x | 0.72x | 0.53x | 0.61x |
| Asset Growth % | 124.44% | 35.95% | 29.59% | 32.13% | 18.69% | -6.75% | 30.03% | - |
| Total Current Liabilities | 395.45M | 369.66M | 295.5M | 253.82M | 207.78M | 186.57M | 159.38M | 99.16M |
| Accounts Payable | 20.47M | 16.83M | 11.08M | 8.28M | 4.61M | 9.55M | 4.73M | 5.36M |
| Days Payables Outstanding | 63.48 | 81.74 | 64.59 | 56.79 | 33.17 | 81.87 | 45.55 | 54.61 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 796.69M | 278.24M | 217.64M | 196.59M | 153.34M | 123.68M | 106.1M | 69.79M |
| Other Current Liabilities | 368.86M | 0 | 0 | 9.04M | 0 | 0 | 0 | 0 |
| Current Ratio | 1.66x | 1.56x | 1.92x | 1.66x | 1.42x | 1.46x | 2.03x | 2.64x |
| Quick Ratio | 1.65x | 1.54x | 1.89x | 1.62x | 1.38x | 1.43x | 2.00x | 2.60x |
| Cash Conversion Cycle | 38.98 | 35.73 | 62.46 | 98.12 | 146.24 | 74.03 | 124.46 | 79.69 |
| Total Non-Current Liabilities | 93.73M | 84.88M | 59.05M | 244.85M | 121.65M | 226.56M | 141.2M | 122.25M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 71.61M | 18.67M | 6.84M | 9.16M | 10.35M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 76.49M | 16.68M | 6.95M | 188.59M | 69.13M | 190.13M | 107.76M | 103.32M |
| Total Liabilities | 489.18M | 454.53M | 354.55M | 498.67M | 329.43M | 413.13M | 300.58M | 221.41M |
| Total Debt | 23.35M | 22.67M | 10.97M | 14.13M | 15.36M | 0 | 0 | 0 |
| Net Debt | -199.7M | -101.79M | -180.69M | -175.39M | -72.29M | -145.97M | -128.71M | -76.55M |
| Debt / Equity | 0.04x | 0.05x | 0.03x | 0.41x | 0.21x | - | - | - |
| Debt / EBITDA | 0.25x | 0.29x | 0.16x | 0.33x | 1.50x | - | - | - |
| Net Debt / EBITDA | -2.13x | -1.30x | -2.68x | -4.06x | -7.06x | -7.01x | -8.53x | -29.91x |
| Interest Coverage | - | - | -0.79x | - | 811.47x | 538.94x | 8.01x | 4.39x |
| Total Equity | 579.31M | 484.32M | 336.02M | 34.21M | 73.86M | -73.35M | 63.8M | 58.83M |
| Equity Growth % | 145.74% | 44.13% | 882.17% | -53.68% | 200.71% | -214.96% | 8.46% | - |
| Book Value per Share | 2.28 | 1.94 | 1.60 | 0.18 | 0.38 | -0.45 | 0.34 | 0.31 |
| Total Shareholders' Equity | 579.31M | 484.32M | 336.02M | 34.21M | 73.86M | -73.35M | 63.8M | 58.83M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -42.57M | -86.54M | -164.86M | 118.14M | 199.24M | 78.44M | 28.34M | 32.56M |
| Treasury Stock | -85K | -85K | -85K | -85K | -85K | -85K | -85K | 0 |
| Accumulated OCI | -804K | 2.22M | 2.09M | 1.05M | 331K | 1.37M | 1.32M | 804K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CLBT stock.
As of 2025, Cellebrite DI Ltd. (CLBT) had total assets of $938.9M including $575.9M in current assets.
Cellebrite DI Ltd. (CLBT) carries total debt of $22.7M, offset by $437.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Cellebrite DI Ltd. (CLBT) has total shareholders' equity (book value) of $484.3M ($1.94 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Cellebrite DI Ltd. (CLBT) reported a current ratio of 1.56x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Volatile liquidity and deferred revenue
Balance Sheet Strengthening Through Accumulated Earnings
According to reported quarterly balance sheets, CLBT's total assets expanded from $556.6M in 2024Q2 to $1.1B in 2026Q3, while retained earnings improved from a deficit of $184.1M to $42.6M, suggesting a materially strengthened equity base over the period.
The shift from a negative equity position in 2024Q2 to $579.3M of equity by 2026Q3 appears driven mainly by sustained net income and capital inflows rather than balance sheet restructuring. The narrowing accumulated deficit suggests the business is beginning to generate retained profits, although the magnitude of asset growth partly reflects cash build and acquired goodwill, which investors should monitor for quality.
Negligible Leverage Limits Refinancing Exposure
Based on reported figures, CLBT carried total debt of only $23.4M against $579.3M of equity in 2026Q3, yielding a debt-to-equity ratio of roughly 0.04, which indicates minimal reliance on borrowed capital.
Debt has remained in a narrow $10.6M to $23.4M range across the period, suggesting leverage is not a strategic lever for growth and that refinancing risk is limited. The low leverage implies that cash flow durability is not constrained by debt service, though the small debt base also means the company has little use for its balance sheet capacity beyond operating needs.
Cash Buffer Remains Volatile Quarter to Quarter
As reported in the quarterly filings, CLBT's cash balance swung from $124.5M at year-end 2025 to $281.4M in 2025Q3 and back to $223.1M in 2026Q3, with the current ratio holding between 1.53 and 2.11 across the period.
A current ratio consistently above 1.5 suggests short-term obligations are comfortably covered, though the quarterly cash swings point to timing effects tied to collections and billing rather than a stable structural reserve. Investors should monitor whether the lower cash points in late 2025 and early 2026 reflect working capital absorption that could recur.
Goodwill Step-Up Inflates Asset Base
Based on reported balance sheets, CLBT's goodwill rose from $28.7M to $119.6M between 2025Q2 and 2025Q4, a roughly fourfold increase that accounts for a meaningful share of the expansion in total assets.
The jump in goodwill appears to reflect an acquisition-related step-up, which lifts asset values without adding tangible productive capacity, and tangible PPE of roughly $40M is modest relative to total assets. This asset mix suggests an asset-light model where impairment risk on the acquired goodwill warrants monitoring if integration underperforms.
Deferred Revenue Signals Subscription Base Durability
According to reported quarterly figures, CLBT's deferred revenue grew from $226.3M in 2024Q2 to $327.8M in 2025Q4 before reading $0 in 2026Q3, a data gap that prevents confident read-through on forward billings.
The steady build in deferred revenue through 2025 suggests a growing contracted, billed-in-advance customer base consistent with the subscription transition. The unavailable 2026Q3 reading means the most recent forward indicator cannot be verified from the supplied data, so this should be treated as unresolved rather than as evidence of contraction.
Goodwill and Working Capital Flatter Headline Strength
Based on reported figures, a substantial part of CLBT's asset growth and quarterly cash variability appears linked to goodwill additions and working capital timing rather than organic cash generation, which may make headline balance sheet strength look better than underlying conditions.
Because goodwill increased by roughly $91M in a single step while cash moved sharply with billing cycles, the reported equity and asset expansion may overstate the durability of the earnings base. Investors should look through to free cash flow conversion and stock-based compensation, which as reported contributed material non-cash add-backs, before treating the balance sheet as fully self-funding.